We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CXSE3:BMFBOVESPACaixa Seguridade Participacoes SA Analysis

Data as of 2026-06-05 - not real-time

R$17.45

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Caixa Seguridade (CXSE3) is trading at R$17.45, well below its DCF fair value of roughly R$23, indicating a material discount. The company posted a 7.6% revenue increase to R$1.5 bn and earnings grew 13.2% year‑over‑year, driven by strong performance in capitalisation and residential insurance. Margins remain exceptional – gross margin near 89% and operating margin above 81% – and cash generation is robust, with free cash flow exceeding R$3.7 bn. The dividend payout of 89% of earnings supports an 8% yield, and the balance sheet is ultra‑conservative (debt‑to‑equity 0.013). Technicals show the price hovering just under the 20‑day SMA (17.55) and 50‑day SMA (18.06), with a neutral trend, RSI at 45 and a bullish MACD crossover, while volume is rising. Overall, the stock combines deep value, solid earnings quality and a generous, sustainable dividend.
Given the upside potential of roughly 11% to the DCF target and the low‑beta, low‑volatility profile, the investment case is strongest for investors seeking income and defensive exposure in Brazil’s insurance sector.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Price below short‑term moving averages indicating near‑term upside
  • Increasing volume supporting momentum
  • Strong cash flow covering high dividend payout

Medium Term

1–3 years
Positive
Model confidence: 9/10

Key Factors

  • Undervaluation versus DCF fair value (+11% upside)
  • Sustained earnings growth and high profitability margins
  • Low beta and moderate volatility reducing market risk

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable, high‑yield dividend with sustainable payout ratio
  • Defensive insurance business with strong ROE (>30%)
  • Conservative capital structure and strong free cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth7.60%
Profit Margin75.12%
P/E Ratio12.0
ROE31.59%
ROA20.33%
Debt/Equity0.01
P/B Ratio3.8
Op. Cash FlowR$3.8B
Free Cash FlowR$3.7B
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI45.0
SupportR$17.23
ResistanceR$18.05
MA 20R$17.55
MA 50R$18.06
MA 200R$16.45
MACDBullish
VolumeIncreasing
Fear & Greed Index93.93

Valuation

Fair ValueR$23.00
Target PriceR$19.41
Upside/Downside11.26%
GradeUndervalued
TypeValue
Dividend Yield8.02%

Risk Assessment

Beta0.49
Volatility21.70%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.